Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st

Abstract: A method of removing a biological contaminant from a mixture containing a biomolecule and the biological contaminant, the method comprising: (a) placing the biomolecule and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; (b) selecting a buffer for the first solvent stream having a required pH; (c) applying an electric potential between the two solvent streams causing movement of the biomolecule through the membrane into the second solvent stream while the biological contaminant is substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; (d) optionally, periodically stopping and reversing the electric potential to cause movement of any biological contaminants having entered the membrane to move back into the first solvent stream, wherein substantially not causing any biomolecules that have entered the second solvent st

Abstract: The claims provide for detecting prions in a sample by (a) subjecting a sample to membrane-based electrophoresis to separate and/or concentrate at least some prions present in the sample; and (b) detecting and or identifying the presence of the separated and/or concentrated prions.

Abstract: An electrophoresis apparatus for processing compounds in small sample volumes comprising a cathode in a static cathode buffer zone or compartment, an anode in a static anode buffer zone or compartment. The cathode disposed relative to the anode so as to be adapted to generate an electric field in an electric field area therebetween upon application of a voltage potential between the cathode and anode. A removable cartridge disposed in the electric field area between the anode and the cathode. The cartridge containing a first non-isoelectric separation barrier and also a second non-isoelectric separation barrier disposed between a selected one of the cathode buffer zone and the anode buffer zone and the first barrier so as to define a first chamber having an interstitial volume of less than 5 ml therebetween.

Abstract: An electrophoretic apparatus comprising: a first electrolyte chamber containing a first electrode; a second electrolyte chamber containing a second electrode; a first sample chamber disposed between the first and second electrolyte chambers and proximate to the first electrolyte chamber; a second sample chamber disposed between the first sample chamber and the second electrolyte; three ion-permeable barriers separating the first electrolyte chamber, the first sample chamber, the second sample chamber, and the second electrolyte chamber, respectively, wherein the ion-permeable barriers impede convective mixing of the contents in each of the respective chambers; a first electrolyte reservoir and a second electrolyte reservoir in fluid communication with the first and second electrolyte chambers, respectively; a first sample reservoir and a second sample reservoir in fluid communication with the first and second sample chambers, respectively; means adapted for communicating a first electrolyte and a second elect

Abstract: An electrophoresis apparatus, comprises a cartridge configured to be removably mounted in the apparatus, and a separation membrane positioned in the cartridge. The separation membrane has a first side along which a first flow path defined in a first grid element and a second side along which a second flow path defined in a second grid element is provided. Restriction membranes separate buffer flow from the first flow path and the second flow path. The apparatus includes connection blocks which house electrodes and inlets and outlets for buffer flow and sample flows. The cartridge is removable from the connection blocks for replacement with another cartridge.

Abstract: An improved cassette for use in the formation of an electrophoretic gel comprises two plates with substantially planar walls having two sides and two ends so arranged in a side by side spaced apart array to form a gel receiving space between them. A plurality of dividing ribs on one or each of the walls extend from a first end of the wall or walls substantially parallel to at least one of the sides thereof to a rib base end. The ribs extend into the space so as to subdivide at least one end of the space into a plurality of substantially parallel wells. A plurality of holes extend through at least one of the walls of the cassette located at or adjacent the base of the dividing rib and aligned with the rib. The arrangement of holes allow sufficient current flow to replace that lost due to the dividing ribs.

Abstract: A method of treating blood or plasma of a subject to remove metabolic contaminants by electrophoresis. Blood or plasma from the subject is placed in a first solvent stream, the first solvent stream being separated form a second solvent stream by an electrophoretic membrane. Applying an electric potential between the two solvent streams causes movement of metabolic contaminants from the blood or plasma through the membrane into the second solvent stream while cellular and biomolecular components of the blood or plasma are substantially retained in the first sample stream, or if entering the membrane, being substantially prevented from entering the second solvent stream.

Abstract: A method of determining the coagulation potential of a plasma sample be pre-incubating the plasma sample with a reagent such that endogenous protein C in the plasma is at least partially converted into activated protein C by the reagent, adding factor Xa which is progressively inactivated by antithrombin III/heparin cofactor 2 during the preincubation, adding an exogenous reagent which activates factor X to Xa or prothrombin to thrombin in a factor V-dependent manner, monitoring a reaction indicative of the rate of coagulation of the plasma sample, comparing that rate of coagulation control, or the equivalent rate determined for an individual without impaired coagulation control, or the equivalent rate determined for the plasma sample in the absence of protein C activator, and determining the coagulation potential of the plasma sample from one or other of the compairsons.

Abstract: A method of separation of an antibody from a mixture of the antibody and at least one contaminant, the method comprising: a) placing the antibody and contaminant mixture in a first solvent stream, the first solvent stream being separated from a second solvent stream by an electrophoretic membrane; b) selecting the pH for the first solvent stream such that contaminants with an isoelectric point (pI) lower than the antibody to be separated will be charged; c) applying an electric potential between the two solvent streams causing movement of at least some of the contaminants through the membrane into the second solvent stream while the antibody is substantially retained in the first solvent stream, or if entering the membrane, being substantially prevented from entering the second solvent stream; d) optionally, periodically stopping and reversing the electric potential to cause movement of any antibody having entered the membrane to move back into the first solvent stream, wherein substantially not causing any c

Abstract: A system for separating biomolecules by electrophoretic separation including a first separation barrier having a defined molecular mass cut-off disposed in the first electric field area, a first restriction barrier disposed between a first cathode zone and a first separation barrier so as to define a first interstitial volume therebetween, a second restriction barrier disposed between the first anode zone and the first separation barrier so as to define a second interstitial volume therebetween, and a pumping means to provide a sample constituent in a selected one of the first interstitial and second interstitial volumes wherein upon application of the first voltage potential, a selected separation product is removed from the sample constituent through the first separation barrier and provided to the other of the first and second interstitial volumes.

Abstract: A polymeric membrane system containing a polymeric membrane and a substrate with interstitial gaps. Polymeric membrane components reside within the interstitial gaps of the substrate and below the surface of the substrate. Also, the layer of polymeric membrane components is thinner than the cross-sectional thickness of the substrate.

Abstract: Methods for removing a non-enveloped virus from a sample containing a target compound and non-enveloped virus contamination place the sample containing the target compound in a solvent chamber of an electrophoresis apparatus having a cathode and an anode, and a first solvent chamber being separated from a second solvent chamber by a separation barrier that has a defined pore size. The solvent chambers and the separation barrier are located between the cathode and anode.

Abstract: A method for altering the initial composition of an ampholytic component containing sample by isoelectric trapping provides for selecting a first isoelectric buffer having a pI value different from the pI value of a first ampholytic sample component in the sample, contacting the isoelectric buffer with the first ampholytic sample component, and obtaining the first ampholytic sample component in a non-isoelectric state on one side of an isoelectric separation barrier at the end of an isoelectric trapping process.

Abstract: An apparatus and method for the separation of molecules having a molecular mass from about 200 to 5000 Da, particularly micromolecules having a molecular mass of less than 5000 Dalton. The apparatus contains an anode, a cathode disposed between the anode and the separation membrane that defines a first interstitial volume therebetween. A first restriction membrane disposed between the anode and the separation membrane defines a second interstitial volume therebetween. Upon application of the voltage potential, a selected separation product is removed from the sample constituent through the separation membrane, and provided to the other of the first and second interstitial volumes.

Abstract: A method for recovering a desired virus type from a mixture of unwanted compounds places a mixture in a first sample chamber of an electrophoresis apparatus that contains a separation membrane located between the first sample chamber and a second sample chamber. Applying an electric potential across the first and second sample chambers separates at least a portion of one virus type on one side of the separation membrane while unwanted compounds are located on the other side of the separation membrane. Either the desired virus type or the unwanted molecules move through the separation membrane. The potential is applied until the required amount of desired virus type is located on one side of the separation membrane. Approximately 50% or more of the desired virus type that is located on one side of the separation membrane remains viable or substantially unchanged after recovery.

Abstract: An electrophoresis system for removing or reducing concentration of a metabolic component from blood or plasma of a subject, the system comprising: (a) a first ion-permeable barrier having a defined pore size and pore size distribution disposed in an electric field area; (b) a second ion-permeable barrier having a defined pore size and pore size distribution disposed between a cathode zone and the first barrier so as to define a treatment chamber therebetween; (c) means adapted for cooling blood or plasma from the subject; (d) means adapted to provide dialysate to the cathode zone and an anode zone; and (e) means adapted to provide blood or plasma from the subject to the treatment chamber; wherein, upon application of the electric potential, a metabolic component from the blood or plasma moves through at least one barrier into at least one of the cathode or anode zones.

Abstract: The claims describe methods for isolating functionally active Factor VIII using a membrane-based separation system containing a separation membrane to create a first and second interstitial volume between at least two restriction membranes. One or more stabilizing agents are added to the sample and/or an interstitial volume. A solvent in the first interstitial volume maintains FVIII in a desired charge state. Applying a potential between the first and second interstitial volumes separates FVIII on one side of the separation membrane from unwanted molecules on the other side of the separation membrane. These methods may also be used as a substitute for one or more steps in a conventional purification scheme for the separation of native or recombinant FVIII.

Abstract: The claims relate to methods and assays for capturing or detecting prions in a sample using prion-binding materials as well as methods of separating prions from a sample. A method selects a prion-binding material in the form of fibrin(ogen), fibrin(ogen)-related material, fibrin(ogen)-derived material, or mixtures thereof, and contacts a sample with the prion-binding material, such that prions contained in the sample are bound to or associated with the prion-binding material. In another aspect, an assay for detecting the presence of prions obtains prion-binding material in the form of fibrin(ogen), a fibrin(ogen)-related material, a fibrin(ogen)-derived material, or mixtures thereof, contacts the prion-binding material with the sample which may contain prions such that prions contained in the sample are bount to or associated with the prion-binding material, and tests for the presence of prions associated with or bound to the prion-binding material.

Abstract: A polymeric membrane system containing a polymeric membrane and a substrate with interstitial gaps. Polymeric membrane components reside within the interstitial gaps of the substrate and below the surface of the substrate. Also, the layer of polymeric membrane components is thinner than the cross-sectional thickness of the substrate.